Swedbank AB: CVS position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Swedbank AB on CVS, newest first. How the timeline and the estimate are built.
Swedbank AB held 2,295,831 CVS shares at 2026-06-30 per its 13F-HR filed 2026-07-15.
the latest 13F is the newest step
- period ended2026-06-3013F 2,295,831 sharesChange vs previous 13F +17,598 shares
0.2% of the 13F portfolio, value $237,503,716.
13F-HR 0000946431-26-000007 filed by Swedbank AB
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 2,278,233 sharesChange vs previous 13F +5,460 shares
0.17% of the 13F portfolio, value $163,622,697.
13F-HR 0000946431-26-000005 filed by Swedbank AB
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F/A 2,272,773 sharesChange vs previous 13F +23,989 shares
0.17% of the 13F portfolio, value $180,367,264.
13F-HR/A 0000946431-26-000003 filed by Swedbank AB
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 2,248,784 sharesChange vs previous 13F +5,870 shares
0.17% of the 13F portfolio, value $169,535,830.
13F-HR 0000946431-25-000012 filed by Swedbank AB
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 2,242,914 sharesChange vs previous 13F +837,102 shares
0.17% of the 13F portfolio, value $154,716,209.
13F-HR 0000946431-25-000008 filed by Swedbank AB
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F 1,405,812 sharesChange vs previous 13F not available
0.08% of the 13F portfolio, value $63,106,899.
13F-HR 0000946431-25-000002 filed by Swedbank AB
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).